About our Executive Committee Members
Tevel's angel club executive committee is our backbone, volunteering valuable time to help Tevel with its esteemed pledge to support Israel.
Tevel angel club has recognized a group of well-established professionals involved in Israeli-technology, with a long track record of initiating, investing in and/or developing multiple successful technology companies.
The prominent members of our executive committee help us screen dozens of Israeli early-stage companies who register with Tevel angel club annually, in order to choose a selective group of four to five promising companies that will have the prestigious opportunity to present at Tevel angel club meetings.
Our team (in alphabetical order)
Arik Arad is currently the President of Arocon, Inc., a global security company that develops and markets a wide range of security solutions. From 2003 to 2005, Mr. Arad served as Executive Vice President of Arotech Corp., President and CEO of Arocon Security Corporation, a subsidiary of Arotech Corp., and Chairman of IES Interactive and AoA–Armour of America. From 1992 to 2003, Mr. Arad acted as a liaison between the Shopping Centers Association of Israel and the Ministry of Defense in Israel. An expert on security and antiterrorism, Mr. Arad has more than 25 years experience in working with government, military, law enforcement and Fortune 500 companies worldwide. His expertise includes assessing security requirements, security planning and implementation, security training programs and proactive security follow–up. Mr. Arad is a graduate of Harvard Business School and Haifa University.
Dr. Nathan Baruch has joined IDT Ventures in January 2006 where he is engaged in fund raising and managing the NJ based office of IDT Ventures dealing with early stage start up companies. Prior to that he was the founder and owner of Natbar, an Israeli privately owned Business Development Company granting an array of services including business development and fund raising. Mr. Baruch was a co-founder and CEO of an International Trade Company representing various Israeli companies worldwide while generating new accounts for manufacturers of consumer goods in the US and Europe as well as co-founder and SVP of Marketing of a joint subsidiary of Tadiran, Israel’s largest electronics company and Perceptronics-USA, a California based company. He served 15 years in the Israeli Defense Forces (Lt. Colonel) leading a multidiscipline team of R&D for the Armored Corp. Mr. Baruch has over 20 years of experience in marketing, sales and management of companies of diverse disciplines. Mr. Baruch holds an MA in Industrial Psychology from Bar-Ilan University, Israel and a PhD in Business Administration from Washington University.
Ronen A.Bojmel is a Partner and a Managing Director of Miller Buckfire & Co., LLC, a New York-based investment bank focusing on corporate restructuring. Prior to joining Miller Buckfire, Ronen was a member of the financial restructuring group of Wasserstein Perella & Co./ Dresdner Kleinwort Wasserstein, which he joined in 1996. Ronen’s restructuring transaction experience includes among others representing Foamex International Inc, J.L French, Autocam Corporation, Progressive Moulded Products Limited, Vulcan Inc. (on its investment in Charter Communications), Grupo TMM, ad hoc unsecured creditors committee of Delta Air Lines, Brokat AG, Crown Cork & Seal, Telenet NV, Gilat Satellite Networks Ltd, CRIIMI MAE Inc, Avianca Airlines. Ronen is a frequent speaker in restructuring-related conferences. Ronen received the 2005 Transaction of the Year award from the Turnaround Management Association on his work for Grupo TMM. Prior to joining the restructuring group, Ronen advised in various leveraged finance and merger and acquisition transactions involving among others Philip Morris Companies, Inc., Rohm & Haas Co., Imax Corporation, Power Bar, Inc., Washington Homes, Inc., Anvil Knitwear, Nortek Inc., Casino Magic, Keystone Consolidated Industries and Shoppers Food Warehouse Corporation. Prior to joining Wasserstein Perella & Co., Ronen was an agent for aviation security operations under the Consul General of the Government of Israel in New York. Ronen resides in New York with wife Orit and son Daniel.
Robert J. Evans, M.D graduated from New York University Medical School in 1984 and completed his fellowship in Cardiovascular Disease and Electrophysiology in 1990 at Cedars-Sinai Hospital. He was Chief of the Electrophysiology service and head of a research group at Long Island Jewish Hospital from 1990-1999. The research group has published extensively in acclaimed medical journals, and has national and international stature. While at LIJ, he co-founded (and served as CEO and President) Prisma Medical Technologies (a VC backed company) based on licensed from the hospital and his research. He currently serves as CEO of Althera Medical and is a board member in numerous other medical device companies in which he led an angel investment. He is an Associate Clinical Professor of Medicine and Chief of EP at Beth Israel Medical Center in Manhattan. He has extensive experience working with and advising and investing in medical device companies including Estech, Atricure, Impulse Dynamics, BioSense, Guidant, Medtronic, St. Jude, and C.R. Bard.
Shoshana (Shosh) Friedman is a partner and VP Regulatory Affairs at BioVance Medical. She has more than 15 years of experience in the fields of regulatory affairs, clinical trials, and quality assurance of medical devices and biotechnology. She is a highly respected expert and speaker in international regulatory affairs, clinical trials and quality assurances and is considered a pioneer in the regulatory affairs community. In recognition of her achievements in the field, she was awarded in 2005 the Richard E. Greco Award by the Regulatory Affairs Professionals Society (RAPS), the highest honor bestowed by RAPS upon outstanding leaders who have made significant contributions in the field. In her many years of activity she has succeeded in educating medical companies in the implementation of regulatory requirements as an integral and critical part of their activity for a successful entrance into the international markets. During 2002-2006 Mrs. Friedman was Senior Vice-President, Regulatory and Clinical Affairs and member of the senior management of Given Imaging (NASDAQ: GIVN). She has been a member of the company Advisory Board since June 1997 and, as the company consultant, led the activities for getting marketing authorization worldwide. Before joining Given Imaging, Shosh held the position of Managing Director, of Push-med Ltd., a regulatory consulting firm that she founded, which provides regulatory, QA, and clinical services to medical device and biotechnology companies. Prior to this position, Shosh was Regulatory, Clinical and QA Director at InStent Ltd., an Israeli medical device company that was acquired by Medtronic Inc. on 1996. Mrs. Friedman holds a B.Sc. in mathematics and physics from Haifa University, a Business Administration Certificate (with Honors) from Hebrew University, a QA Lead Assessor certification from Bywater, and a Regulatory Affairs Certification (RAC) from RAPS. 
Tzameret Fuerst is the Chairwoman and a Founding Member of Dor Chadash. Tzameret has over 12 years of experience in marketing multi-national brands in the technology and consumer goods sectors in Israel and in the USA. In the USA she served as Director of Strategic Initiates for the online merchandizing company RichFX, backed by Morgan Stanley, Mellon Ventures, Pitango and more. In Israel, her roles included serving as Director of Marketing for Lipski Ltd, the publicly traded subsidiary of Keter Plastic, the largest plastic manufacturer in Israel and serving as a Strategic Planner at D’Arcy/Geller Nessis advertising agency managing clients such as Procter & Gamble, Nokia, Holiday Inn, Energizer and Careline. She took a break from the business world to leverage her energy and expertise for the benefit of the Jewish community, and got so hooked that it became a full-time volunteer endeavor. She is most passionate about sharing the diversity and inventiveness of Israeli culture and contemporary life. While Dor Chadash is her primary commitment, Tzameret is active in the Council for Young Jewish Presidents, artis Israeli Contemporary Art, The Bezalel Art Academy, Meir Panim and is involved in various other community projects. She was also the co-founder of the Israeli Women’s Alliance and served as past Chair of artis Israeli Contemporary Art. Tzameret is the co-chair of the Philanthropy initiative at Tevel angel club.
Yaron Galai is the co-founder and SVP of Quigo, Inc. (www.quigo.com), a provider of performance-based marketing solutions for advertisers and premium publishers. He previously served as the CEO of the company for three years. Mr. Galai is also co-founder and CEO of Outbrain, Inc. (www.outbrain.com), a startup developing a blog and RSS rating platform. Outbrain caters to RSS aggregators, online publishers, and bloggers. Prior to founding Quigo, Mr. Galai was co-founder & VP Business Development at Ad4ever, a developer of rich-media advertising technologies for the web which was later acquired by Atlas (a division of aQuantive – www.aquantive.com). Earlier, he was the founder of NetWorks Web Design - an SEO and web design firm. At NetWorks he oversaw the production and search engine optimization of over 30 websites. Mr. Galai studied industrial design at the Holon Technological Institute, and is a Major (reserve) officer in the Israel Navy.
Alon Geva is currently the Vice President for Business Development and Technology at XMPie, recently acquired by Xerox (NYSE: XRX). His record includes more than a decade of experience in technology and information systems including embedded-computing systems, distributed system, networking and security. Prior to XMPie Mr. Geva was a co-founder and CTO of Nuvisio. He initiated the acquisition of Nuvisio by XMPie, and was a key member of the team responsible for its successful completion. Mr. Geva was an officer with the elite Intelligence unit of the Israeli Defense Forces where he managed and developed a number of state-of-the-art software projects and system solutions. He received an MBA and a B.Sc in Mathematics and Computer Sciences, both with honors, from Tel-Aviv University.
Dr. Avraham Kadar, M.D. is the Founder, Chairman and CEO of BrainPOP. Having started or invested in several Internet and technology companies, Dr. Kadar is a serious and successful entrepreneur. One of his most notable startups, BrainPOP, was born in 1999 when Dr. Kadar tried to find a way to teach his young patients about asthma and allergies. He created a short educational animated video and found that it not only captured their attention, but also sparked their interest in learning more. Now Dr. Kadar has gone from educating his patients to educating a nation, creating a library of more than 650 animated BrainPOP movies, which are being used by more than 25 percent of U.S. schools. BrainPOP Jr. is a new venture by Dr. Kadar, focusing on younger students, K-3. The company is quickly replicating the success of Dr. Kadar’s original BrainPOP. Dr. Kadar is board certified in Pediatrics and in Diagnostic Laboratory Immunology, and practices in New York City and Westchester, New York. He holds the position of Assistant Clinical Professor, Division of Allergy and Immunology, at the Albert Einstein College of Medicine. A graduate of Sackler Medical School Tel Aviv Israel, Dr. Kadar trained in Pediatrics in Israel and at the Albert Einstein College of Medicine and Montefiore Hospital in New York. He was a Fellow in the Laboratory of Clinical Investigation at the National Institutes of Health (NIH) in Bethesda, MD. Dr. Kadar serves as AditAll’s Founder, Chairman and CEO and works closely with the company’s other executives in defining and executing overall strategy.
Nimrod Lev, Founder, kSolo
Michael E. Ronen is a member of the Mergers Leadership Group and is responsible for the execution of many of the firm's Telecommunications, Media and Technology merger deals in the United States. Michael has a particular focus on cross-border
transactions and transactions involving financial sponsors. Michael joined Goldman Sachs in 1998 as an associate in the Communications, Media and Entertainment group. He later became the business unit manager for that group and subsequently moved to work with many of the firm's important Media, Telecom and Technology clients. He became a managing director in 2006. Prior to joining the firm, Michael served in the Israeli Air Force Intelligence Corps and later practiced law as an attorney in Israel, specializing in bankruptcies and financial restructurings. Michael earned an LLB (JD) from Tel-Aviv University in 1994 and graduated from the Stern School of Business at NYU with an MBA, with distinction, in 1998. He lives in New York with his wife, Shira, and their two children.
Dr. Zeil Rosenberg is a Managing Director and partner at BioVance Medical, an advisory and investment company in the MedTech arena. He also serves as the CEO of Anadis Ltd (ASX: ANX), a biotechnology company. He is a recognized physician-leader and business executive with 20 years of achievement in the global healthcare industry. He served for 8 years at Becton Dickinson & Co. (NYSE: BDX) as Worldwide Business Leader and Medical Director for Immunization where he led a dedicated global team responsible for development, commercialization, and marketing of a broad portfolio of specialized medical devices and systems for safe delivery of vaccines. In the bio-defense arena, Dr. Rosenberg led initiatives for delivery of bio-defense vaccines and for solutions to problems of mass immunization, such as against influenza or smallpox, helping bring new products from concept through clinical studies and into the marketplace. Dr. Rosenberg has previously worked as national Immunization Advisor for the Ministry of Health, Indonesia; AAAS Science and Diplomacy Fellow at USAID in Washington DC; Director, Family Health in the New York State Health Department, and as Director, National Programs at the Children's Health Fund. Dr. Rosenberg is a Specialty Fellow, American Academy of Pediatrics and Fellow, American College of Preventive Medicine. He earned his MD at the University of California, San Francisco and completed his residency at Cornell University Medical Center. He received his MPH in Epidemiology from Columbia University and BA in Economics from Stanford University.
Yaron Samid is the co-founder and CMO of Pando Networks Inc., the Internet's fastest growing Hybrid Peer-to-Peer content delivery network with over 14 million users in only its first year. Yaron is a serial entrepreneur that has designed products and built companies that have empowered millions of people to create, consume, distribute and monetize digital media. Yaron started Pando Networks after co-founding DeskSite TV, the Internet's first PCTV network. Previously Yaron held senior Marketing and Product Management positions at Zend, BackWeb and Register.com. Yaron is the founder and organizer of NY-Israel Tech, a peer group of NY-based Israeli high-tech founders and professionals that meet monthly to showcase and support local Israeli high-tech startups. He is also the founder of NY Video 2.0, a 1,200+ member monthly meetup of NY-based online video startups and media companies.
Talli Somekh is a general partner in Musea Ventures, a family venture fund focusing on investments in alternative energy and the emerging field of synthetic biology. He has led the firm's investment Acoustic Cytometry Systems ( http://www.acousticyte.com) and CODA Genomics (http://www.codagenomics.com). Talli is also a member of the Industry Advisory Board of the BioBricks Foundation ( http://www.biobricks.org/), an organization recently formed to advance technical and legal standards for the field of synthetic biology.
Ido Stern Ido Stern is a Managing Director of Technology Investment Banking at Oppenheimer & Co., previously CIBC World Markets, in New York. Mr. Stern joined Oppenheimer's Technology Investment Banking Group in 1997. Mr. Stern heads Oppenheimer's electronics investment banking group. He is focused on companies in the electronics industry including electronics capital equipment & materials, display technologies, digital media, memory and IP semiconductors and emerging electronics nanotechnology.
Oppenheimer has been consistently one of the most active investment banks to the electronics industry during his tenure. Mr. Stern has initiated the banks' focus on the display industry and has been a leading banker catering to Israeli technology companies listed on the NASDAQ. Mr. Stern has completed numerous public offerings, mergers & acquisition advisory and private placement assignments for both domestic and international clients. Prior to Oppenheimer, Mr. Stern had been with Bankers Trust and held R&D roles with several technology companies including Intel and Kulicke & Soffa. Mr. Stern holds an MBA from Columbia Business School and a B.Sc in Computer Engineering from Technion, Israel both with honors.
Rony Zarom is the Founder and Chairman of Decima Ventures and has established himself as one of most successful entrepreneurs in the technology sector. His most recent success was the founding of Exalink, a provider of a complete suite of mobile Internet solutions that combined infrastructure products and software applications. Only 14 months after the company was established, Exalink merged with Comverse (NASDAQ: CMVT, http://www.comverse.com/) in a deal valued at approximately $550 million. Mr. Zarom’s business track record includes a number of other impressive achievements. Prior to founding Exalink, he held several senior management positions at elroNet, which merged with Netvision and became Israel's leading Internet service provider. Mr. Zarom also served as the managing director at ELRON, heading up a new venture in the IP Telephony field known as i-Fax. Following the merger of i-Fax, he served as the executive vice president of business development at ArelNet, a leader in the IP telephony field.